$ANF

Dick's Sporting Goods To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday - Abercrombie & Fitch (NYSE:ANF), Bilibili (NASDAQ:BILI)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Ascendiant Capital cut 60 Degrees Pharmaceuticals Inc ( NASDAQ:SXTP ) price target from $3 to $2.8.

Original reporting
Benzinga · Avi Kapoor
Published Nov 28, 2025, 1:35 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Nov 28, 2025, 2:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Dick's Sporting Goods To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday - Abercrombie & Fitch (NYSE:ANF), Bilibili (NASDAQ:BILI) — source image
Decision brief

The 30-second read

$ANFNeutralMed
01

Why it matters

While analyst upgrades can influence short-term trading, they should be corroborated with technical analysis and macroeconomic factors.

02

Market read

The news primarily impacts U.S. retail and financial sectors, with some influence on related industries. The overall market impact remains moderate, with short-term trading opportunities for active traders.

03

What to watch

Market volatility, broader economic conditions, and potential earnings reports could influence outcomes beyond analyst forecasts.

Timing: Short-term (next 1-2 weeks)

Background

Recent analyst forecasts indicate a potential rally for certain retail stocks, notably Abercrombie & Fitch, amid broader market optimism.

Company-level read

Ticker impact

$ANFNeutralMedium confidence
Context

High relevance due to analyst forecasts and market sentiment.

Expected impact

Moderate bullish movement expected over the next 1-2 weeks.

Evidence & confidence

Based on recent analyst upgrades and market sentiment, a positive price movement is plausible. However, the neutral overall sentiment and lack of technical confirmation introduce some uncertainty.

$BILINeutralLow confidence
Context

Low relevance; minimal impact due to neutral sentiment score and small relevance percentage.

Expected impact

Limited or negligible impact expected.

Evidence & confidence

The sentiment score is neutral, and the relevance score is low, indicating limited influence on trading decisions.

$SXTPNeutralLow confidence
Context

Low relevance; minimal impact due to neutral sentiment and small relevance percentage.

Expected impact

Negligible expected price change.

Evidence & confidence

The neutral sentiment and low relevance suggest limited trading significance.

$BILINeutralLow confidence
Context

Duplicate entry; already analyzed above.

Expected impact

Limited impact.

Evidence & confidence

Redundant data; no new information.

Market effects

Potential positive influence on retail and consumer discretionary sectors due to bullish analyst forecasts for ANF.

Limited; primarily U.S.-focused news with minimal regional implications.

Low; the news does not significantly affect global markets.

Counterpoint

The neutral sentiment and lack of technical confirmation suggest caution; the anticipated rally may not materialize.

Key entities

  • Abercrombie & Fitch

    A global retailer specializing in casualwear.

  • Bilibili

    A Chinese video-sharing website and streaming platform.

  • Six Degrees Pharmaceuticals

    A biotech firm focused on drug development.

  • Barclays

    A multinational investment bank and financial services company.

  • FIVE

    Five Below, a retailer offering value-priced products.

Related articles

$SXTPMedAI 8/10

60 Degrees Pharmaceuticals Prices $1.0M Private Placement At $1.74 Per Share; Stock Down

60 Degrees Pharmaceuticals (SXTP) said it agreed to a Nasdaq-priced at-the-market private placement. It will sell 574,713 shares (or pre-funded warrants) at $1.74 per share, with Series A warrants and Series B warrants exercisable at $1.49. Gross proceeds are about $1.0 million. Net proceeds will fund working capital. Closing expected around July 31, 2026.

$NCLHMedAI 9/10

US stocks approach records as dropping oil prices ease stress

U.S. stocks neared record highs as Brent crude fell and eased inflation pressure. The S&P 500 rose less than 0.1% and the Dow gained 0.4% and Nasdaq 0.1%, with all setting records. Brent dropped 4.6% to $92.25 and U.S. crude 5.5% to $88.68. Airlines and retailers led gains; oil firms fell. Treasury 10-year yield eased to 4.48%.

$NCLHMedAI 8/10

US stocks inch to more records after oil prices drop

U.S. stocks edged to more records Wednesday as Brent crude fell 4.6% to $92.25 and U.S. crude dropped 5.5% to $88.68, easing inflation pressure. The S&P 500 rose 0.1% to 7,520.36, the Dow gained 0.4% to 50,644.28, and the Nasdaq added 0.1% to 26,674.73. Airlines climbed on lower fuel costs; oil-and-gas fell. Treasury 10-year yields eased to 4.48%.

$DALMedAI 9/10

US stocks inch to more records after oil prices drop

U.S. stocks edged to more records Wednesday as Brent crude fell 4.6% to $92.25 and U.S. crude dropped 5.5% to $88.68, easing inflation pressure. The S&P 500 rose <0.1% to 7,520.36, the Dow gained 0.4% to 50,644.28, and the Nasdaq added 0.1% to 26,674.73. Airlines rose on lower fuel costs; oil-and-gas stocks fell.

$ANFHighAI 9/10

Why Abercrombie Stock Rebounded Today

Abercrombie & Fitch shares rose after the company reported fiscal 2026 Q1 results that beat Wall Street estimates. Net sales grew 2% to $1.1B and marked 14 straight quarters of gains, though EMEA sales fell 10%. Earnings fell 8% to $1.47/share but topped the $1.28 estimate. Operating margin fell to 8% from 9.3%. Management expects tariff headwinds to ease and full-year net sales growth of 3%–5% with EPS of $10.20–$11.00, targeting $450M in buybacks.